Ovarian cancer has a high mortality and delayed diagnosis. Several immunological alterations take place during ovarian carcinogenesis, and can be of value in the surveillance of the diseases. This research was conducted to evaluate serum immunoglobulin levels in women with ovarian cancer and to assess their role in disease process. The present study is composed of 85 women (mean age = 62.03±12.4 yrs) with clinically and pathologically confirmed ovarian cancer and 65 healthy females as a control group (mean age = 61±12.1 yrs). ELISA test was achieved for the determination of serum [IgG, IgA, IgM]. The findings of current study illustrated significant (P=0.001) increase in serum IgG, IgA, and IgM levels as compared to controls. Analyzing seru...
The availability of an ideal serum tumor marker would be of great clinical benefit for both the diag...
Purpose of investigation: The aim of our study was to assess whether serum levels of serum insulin-l...
Epithelial ovarian cancer accounts for 5% of all cancer deaths and greater than 50% of all gynaecolo...
Abstract: New diagnostic methods are being sought for ovarian cancer due to its higher prevalence, w...
Previous studies indicated that glycans in serum may serve as biomarkers for diagnosis of ovarian ca...
Summary.-One hundred and sixty women admitted for breast tumour biopsy to the King's College Ho...
Most women with a clinical presentation consistent with ovarian cancer have benign conditions. There...
Background: Very few studies have been done to evaluate the level of serum immunoglobulins (IgG, IgM...
Background: Most women with a clinical presentation consistent with ovarian cancer have benign condi...
THESIS 10070Ovarian cancer is the most deadly gynaecological malignancy and 70% of all women with ov...
Due to late diagnosis, ovarian cancer is the most deadly gynecologic malignancy. Inflammation is on...
Purpose: To evaluate if serum cytokine levels could be used as diagnostic or prognostic markers in o...
Interleukin-2 receptor (IL-2R) can be detected in serum. We estimated the IL-2R in the serum of 78 w...
Purpose: To evaluate if serum cytokine levels could be used as diagnostic or prognostic markers in o...
Epithelial ovarian cancer is a significant cause of mortality both in the United States and worldwid...
The availability of an ideal serum tumor marker would be of great clinical benefit for both the diag...
Purpose of investigation: The aim of our study was to assess whether serum levels of serum insulin-l...
Epithelial ovarian cancer accounts for 5% of all cancer deaths and greater than 50% of all gynaecolo...
Abstract: New diagnostic methods are being sought for ovarian cancer due to its higher prevalence, w...
Previous studies indicated that glycans in serum may serve as biomarkers for diagnosis of ovarian ca...
Summary.-One hundred and sixty women admitted for breast tumour biopsy to the King's College Ho...
Most women with a clinical presentation consistent with ovarian cancer have benign conditions. There...
Background: Very few studies have been done to evaluate the level of serum immunoglobulins (IgG, IgM...
Background: Most women with a clinical presentation consistent with ovarian cancer have benign condi...
THESIS 10070Ovarian cancer is the most deadly gynaecological malignancy and 70% of all women with ov...
Due to late diagnosis, ovarian cancer is the most deadly gynecologic malignancy. Inflammation is on...
Purpose: To evaluate if serum cytokine levels could be used as diagnostic or prognostic markers in o...
Interleukin-2 receptor (IL-2R) can be detected in serum. We estimated the IL-2R in the serum of 78 w...
Purpose: To evaluate if serum cytokine levels could be used as diagnostic or prognostic markers in o...
Epithelial ovarian cancer is a significant cause of mortality both in the United States and worldwid...
The availability of an ideal serum tumor marker would be of great clinical benefit for both the diag...
Purpose of investigation: The aim of our study was to assess whether serum levels of serum insulin-l...
Epithelial ovarian cancer accounts for 5% of all cancer deaths and greater than 50% of all gynaecolo...